The Chosun Ilbo on MSN

Merck's Oral Cholesterol Drug Nears FDA Approval

New drugs that lower cholesterol and treat hyperlipidemia are preparing to enter the market.According to The New York Times ...

LIB Therapeutics Announces Results from Late Breaking Science Presentation at 2025 American Heart Association Meeting in New Orleans November 9, 2025

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (Lerochol®), a ...

Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR | MarketsandMarkets(TM)

DELRAY BEACH, Fla., Oct. 28, 2025 /PRNewswire/ -- The global Cell-free Protein Synthesis Market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a ...

VDAC1 protein can override inhibitor to unleash programmed cell death

The activation and deactivation of apoptosis is a promising field of research in basic biomedical research. The team led by Prof. Franz Hagn from the Chair of Structural Membrane Biochemistry at the ...
Fred Hutch

Bridging the gap between cancer drug target and cancer drug

Fred Hutch Cancer Center prostate cancer researcher and medical oncologist Andrew Hsieh, MD, was recently named a 2024 Harrington Scholar-Innovator. The two-year, $100,000 award, from the Harrington ...